Kim BY - Search Results

1

Corrigendum: Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes.

Qie Y, Yuan H, von Roemeling CA, Chen Y, Liu X, Shih KD, Knight JA, Tun HW, Wharen RE, Jiang W, Kim BY. Qie Y, et al. Among authors: kim by. Sci Rep. 2016 Aug 1;6:30663. doi: 10.1038/srep30663. Sci Rep. 2016. PMID: 27477438 Free PMC article. No abstract available.

2

Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles.

Jiang W, Huang Y, An Y, Kim BY. Jiang W, et al. Among authors: kim by. ACS Nano. 2015 Sep 22;9(9):8689-96. doi: 10.1021/acsnano.5b02028. Epub 2015 Jul 31. ACS Nano. 2015. PMID: 26212564

3

Non-contiguous meningeal metastases of olfactory neuroblastoma.

Jiang W, Liu J, Gullane PJ, Gentili F, Wharen RE, Kim BYS, DeMonte F. Jiang W, et al. J Neurooncol. 2016 Jan;126(1):201-203. doi: 10.1007/s11060-015-1935-6. Epub 2015 Sep 16. J Neurooncol. 2016. PMID: 26376653

4

Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma.

Yushi Q, Li Z, Von Roemeling CA, Doeppler H, Marlow LA, Kim BY, Radisky DC, Storz P, Copland JA, Tun HW. Yushi Q, et al. Among authors: kim by. Oncotarget. 2016 May 31;7(22):32156-71. doi: 10.18632/oncotarget.8537. Oncotarget. 2016. PMID: 27050077 Free PMC article.

5

Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes.

Qie Y, Yuan H, von Roemeling CA, Chen Y, Liu X, Shih KD, Knight JA, Tun HW, Wharen RE, Jiang W, Kim BY. Qie Y, et al. Among authors: kim by. Sci Rep. 2016 May 19;6:26269. doi: 10.1038/srep26269. Sci Rep. 2016. PMID: 27197045 Free PMC article.

6

Breaking Down the Barriers to Precision Cancer Nanomedicine.

von Roemeling C, Jiang W, Chan CK, Weissman IL, Kim BYS. von Roemeling C, et al. Trends Biotechnol. 2017 Feb;35(2):159-171. doi: 10.1016/j.tibtech.2016.07.006. Epub 2016 Aug 1. Trends Biotechnol. 2017. PMID: 27492049 Review.

7

Lessons from immuno-oncology: a new era for cancer nanomedicine?

Jiang W, Yuan H, Chan CK, von Roemeling CA, Yan Z, Weissman IL, Kim BYS. Jiang W, et al. Nat Rev Drug Discov. 2017 Jun;16(6):369-370. doi: 10.1038/nrd.2017.34. Epub 2017 Mar 17. Nat Rev Drug Discov. 2017. PMID: 28303024

8

Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.

Yuan H, Jiang W, von Roemeling CA, Qie Y, Liu X, Chen Y, Wang Y, Wharen RE, Yun K, Bu G, Knutson KL, Kim BYS. Yuan H, et al. Nat Nanotechnol. 2017 Aug;12(8):763-769. doi: 10.1038/nnano.2017.69. Epub 2017 May 1. Nat Nanotechnol. 2017. PMID: 28459470

9

Study of Osteocyte Behavior by High-Resolution Intravital Imaging Following Photo-Induced Ischemia.

Yuan H, Jiang W, Chen Y, Kim BYS. Yuan H, et al. Molecules. 2018 Nov 4;23(11):2874. doi: 10.3390/molecules23112874. Molecules. 2018. PMID: 30400346 Free PMC article.

10

Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery.

Chen Y, Liu X, Yuan H, Yang Z, von Roemeling CA, Qie Y, Zhao H, Wang Y, Jiang W, Kim BYS. Chen Y, et al. Adv Sci (Weinh). 2019 Jan 22;6(5):1802070. doi: 10.1002/advs.201802070. eCollection 2019 Mar 6. Adv Sci (Weinh). 2019. PMID: 30886813 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,360 results

Search Page

Filters